A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that targets platelets – rather than traditional clotting proteins – to help reopen blocked blood vessels in the brain.
A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that targets platelets – rather than traditional clotting proteins – to help reopen blocked blood vessels in the brain.